Department of Endocrinology, Tongji Hospital Affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, China.
Department of Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Nat Commun. 2022 Jun 8;13(1):3301. doi: 10.1038/s41467-022-30757-y.
Exercise benefits M2 macrophage polarization, energy homeostasis and protects against obesity partially through exercise-induced circulating factors. Here, by unbiased quantitative proteomics on serum samples from sedentary and exercised mice, we identify parvalbumin as a circulating factor suppressed by exercise. Parvalbumin functions as a non-competitive CSF1R antagonist to inhibit M2 macrophage activation and energy expenditure in adipose tissue. More importantly, serum concentrations of parvalbumin positively correlate with obesity in mouse and human, while treating mice with a recombinant parvalbumin blocker prevents its interaction with CSF1R and promotes M2 macrophage polarization and ameliorates diet-induced obesity. Thus, although further studies are required to assess the significance of parvalbumin in mediating the effects of exercise, our results implicate parvalbumin as a potential therapeutic strategy against obesity in mice.
运动有益于 M2 巨噬细胞极化、能量平衡,并通过运动引起的循环因子部分保护机体免受肥胖的影响。在这里,通过对久坐和运动小鼠的血清样本进行无偏定量蛋白质组学分析,我们鉴定出钙结合蛋白 parvalbumin 是一种受运动抑制的循环因子。钙结合蛋白 parvalbumin 作为非竞争性 CSF1R 拮抗剂,抑制脂肪组织中 M2 巨噬细胞的激活和能量消耗。更重要的是,血清 parvalbumin 浓度与小鼠和人类肥胖呈正相关,而用重组 parvalbumin 阻断剂治疗小鼠可防止其与 CSF1R 相互作用,并促进 M2 巨噬细胞极化,改善饮食诱导的肥胖。因此,尽管还需要进一步的研究来评估 parvalbumin 在介导运动效应中的意义,但我们的结果表明 parvalbumin 可能是一种针对肥胖的潜在治疗策略。